VERO
Venus Concept Inc
NASDAQ: VERO · HEALTHCARE · MEDICAL DEVICES
$0.31
+0.00% today
Updated 2026-04-30
Market cap
$578190.00
P/E ratio
—
P/S ratio
0.01x
EPS (TTM)
$-45.26
Dividend yield
—
52W range
$0 – $8
Volume
0.0M
Venus Concept Inc (VERO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-24.12M | $-16.16M | $-19.26M | $-28.70M | $-39.59M | $-28.65M | $-19.77M | $-26.98M | $-12.86M | $-11.07M |
| Capital expenditures | $456000.00 | $1.17M | $229000.00 | $1.01M | $1.12M | $291000.00 | $512000.00 | $336000.00 | $116000.00 | $123000.00 |
| Depreciation | $860000.00 | $654000.00 | $574000.00 | $813000.00 | $2.04M | $4.80M | $4.85M | $4.46M | $4.12M | $3.89M |
| Stock-based comp | $429000.00 | $466000.00 | $465000.00 | $667000.00 | $2.16M | $2.14M | $2.07M | $2.10M | $1.57M | $1.04M |
| Free cash flow | $-24.57M | $-17.34M | $-19.48M | $-29.70M | $-40.72M | $-28.94M | $-20.28M | $-27.32M | $-12.97M | $-11.19M |
| Investing cash flow | $-456000.00 | $-1.17M | $1.62M | $-1.01M | $6.38M | $-2.39M | $-552000.00 | $-336000.00 | $-116000.00 | $-123000.00 |
| Financing cash flow | $8.89M | $12.11M | $29.37M | $22.24M | $42.20M | $49.67M | $16.82M | $8.01M | $6.80M | $10.06M |
| Dividends paid | — | — | — | — | — | $3.56M | $293000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $18.63M | — | — | — | — |